April 21, 2021   INNOVATION

FDA approves self-injectable formulation of Xolair

SEATTLE: The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In